| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-09 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.3 | 5e-07 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |